ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.

Executive recruiting firms report a sharp decline in interest in diversity, equity and inclusion hiring initiatives within ...

The field of medical diagnostics and clinical practice is being transformed by the rapid advancement of deep learning ...

DeepSeek has released a new paper, with co-founder Liang Wenfeng credited as a contributor, detailing how its latest large ...

Warren Buffett’s Berkshire Hathaway BRK.A BRK.B just filed its 13F for the first quarter of 2025. Here’s a look at the stocks ...

VNET saw 2025 volatility with AI-driven gains offset by tech sell-offs, solid earnings, and rising risks. Find out why VNET ...

Chinese startup Butterfly Effect, creator of general-purpose AI agent Manus, is reportedly considering relocating its ...

Thomas English AgiBot, a Chinese robotics firm, is beginning to embed homegrown AI systems like DeepSeek into humanoid robots ...

Long before Donald Trump entered the White House for a second time, it was becoming clear we were entering a radically different world. Rising nationalism and increased cross-border friction were ...

We recently published a list of 10 Michael Burry Stocks with Huge Upside Potential. In this article, we are going to take a ...

The Invesco S&P 500 Equal Weight Technology ETF (RSPT) offers a more diversified and resilient approach compared to the ...

We recently published a list of 13 Best AI Stocks to Buy Under $10. In this article, we are going to take a look at where ...